A nonsense mutation was found in exon 23 of the factor VIII gene of a haemophiliac patient with anti-factor VIII antibody. Genomic DNA of lymphocyte cells from the patient analyzed by Southern blot analysis with various segments of factor VIII cDNA revealed that the TaqI site in exon 23 was erased in the patient gene. The 0.3 kbp nucleotide sequence of the exon 23 was cloned and sequenced, and the substitution of nonsense (TGA) codon for the arginine (CGA) codon was found to be the possible cause of the factor VIII deficiency.
INTRODUCTION
Haemophilia A is an X-linked recessive bleeding disorder caused by the molecular alteration of factor VIII, and is observed at a frequency of 10 -4 in males. Recently, cDNA for factor VIII has been cloned and sequenced entirely Toole et al., 1984) . The gene encodes a protein with 2,351 amino acid residues including the initiation codon (position -19). Molecular deficiencies have been reported in factor VIII by several independing groups (Antonarakis et al., 1985; Gitschier et al., 1985 Gitschier et al., , 1986 Youssoufian et al., 1986 Youssoufian et al., , 1987a . Since the size of factor VIII gene is 186 kbp long containing 26 exons, complete sequence of the gene is not easily determined for each of the patient, and the genetic polymorphism at the various sites are analyzed as a linked marker of the genetic defect.
In this report, we found a nonsense (CGA to TGA) mutation, which resulted in the termination at amino acid residue position 2209 in exon 23 of the factor VIII gene. This severe haemophiliac patient had anti-factor VIII antibodies. This patient is one of 64 Japanese haemophilia A patients and 6 cases with anti-factor VIII antibodies studied by us.
CASE REPORT
The patient (15 years of age, male) had a severe haemophilia A, having less than 1~ of factor VIII coagulant activity (VIIIC) assayed by one stage method (Hardisty and Macpherson, 1962) and less than 0.1~ of factor VIII coagulant antigen (VIIICag) assayed by IRMA (Peake et aL, 1979) . He had knee joint haemorrhages and repeated haematuria. At 3 years of age, anti-factor VIII antibody (inhibitor) with maximum titers of 130 Bethesda units/ml was detected. His mother is a carrier (VIIIC 45~, VIIICag 49~, yon Willebrand factor antigen 100~). He has three sisters. One of them is healthy and the other two are heterozygous carriers as detected by coagulant assays and BelI polymorphism (Nishino et al., 1987) .
METHODS
DNA preparation and RFLP analysis. Genomic DNAs of the 70 Japanese haemophiliac patients were isolated from leukocytes and digested with TaqI restriction endonuclease in combination with various other restriction enzymes for RFLPs (restriction fragment length polymorphisms) analysis. Gel electrophoresis, Southern blot hybridization and radioisotope lebeling were performed as described previously (Maniatis et al., 1982) . DNA probes for Southern blot analysis were those as described elesewhere (Antonarakis et al., 1985; Mikami et al., 1988) . Two 17-mer oligonucleotides used as primers for DNA sequencing and a 90-met probe used for library screening were synthesized with the DNA synthesizer (ABI 380 Model; Applied Biosystems Inc., Foster City, Calif., USA).
RESULTS
Genomic DNAs were isolated from leukocytes of patients and digested with restriction endonuclease TaqI for restriction fragment length polymorphism (RFLPs) analysis. Southern blot analysis was performed using two different types of probes, one (probe A) covering exons from I to 12 and the other (robe B+C) covering exons from 14 to 26 (Fig. 1 ). In the initial survey of the DNAs, it was revealed that DNA from one such patient showed no difference in the Southern blot pattern compared with the normal human DNA when probe A was used (Fig. 2 , left two columns) but showed an additional 3.8 kbp fragment instead of two 1,4 kbp and 
5.0Kbp
The restriction map of factor VIII gene using Taq I and the regions detectable 2.4 kbp fragments when a mixture probe B + C was used (Fig. 2 , right two columns). These observations strongly suggested that TaqI site in exon 23 had a mutation in the DNA from this patient. Therefore, the DNA sequence of this TaqI site region was subsequently determined as follows. High molecular weight genomic DNA was prepared by the standard method as described previously (Nishino et al., 1987) from leukocytes of the haemophiliac patient. An EcoRI digest of the DNA was fractionated by gel electrophoresis. A fraction which was 4 to 6 kbp in size was purified and cloned into 2gtl0 phage vectors. After in vitro packaging, the phage lysate was infected to E. coli host, strain C600, and screened for the EcoRI fragment, in which the point mutation in the TaqI site was thought to be containing (Fig. 1) , using a2P-labeled 90-mer synthetic oligonucleotide corresponding to the cDNA region between nucleotide positions 6591 and 6680 (positions are defined as in Ref.) in exon 24. Eight clones out of 5 x 105 independent clones were positive in plaque hybridization with the probe and four of them were further characterized and shown to have the identical 5.0 kbp EcoRI fragment. Two (2F8-232 and 2F8-235) of these four clones were chosen for DNA sequencing. The EcoRI fragments from 2F8-232 and 2F8-235 were transfered to pHSG399 (Takeshita et aI., 1987) at EcoRI site for dideoxy-chain-termination DNA sequencing by using two sequence primers. One primer, TGGCAAT-G T G G A T T C A T (corresponding to the sense sequence between positions 6438 and 6454), was used for the sequencing of the Taq[ site region on one sense strand and the other primer, TCACAGCCCATCAACTC between positions 6566 and 6550 on the antisense strand. Sequence of 300 nucleotides were determined including the TaqI site region (6496 to 6499). Two independent clones showed a completely identical sequence in this region. However, the TaqI site was not found within this region in both two clones. The cytosin residue at nucleotide position 6497 in the normal factor VIII gene was substituted by thymin residue in these clones, resulting in mutation from Arg codon, CGA, to stop codon, TGA (Fig. 3) . Therefore, it was concluded that the difference of TaqI RFLP analysis data between normal and the patient and the deficiency of factor VIII activity in this patient was due to the single nucleotide substitution in the TaqI site in exon 23.
DISCUSSION
In this report, we localized nonsense mutation, from CGA (Arg) to TGA (stop), in exon 23 of factor VIII gene of one haemophiliac patient. CpG dinucleotide is a mutation hot-spot (Barker et aI., 1984) , and 35~o of mutations were found to have occurred within this area in several genetic disorders. According to Cooper and Youssoufian (1988) , it has been confirmed that over 90~ of these mutations are C ~T or C--+A. Haemophilia A is one of these disorders. Seven TaqI sites are found in exons of factor VIII gene (exons 7, 13, 18, 22, 23, 24, and 26) . The TaqI restriction site (TCGA) containing CpG dinucleotide are frequently examined in haemophiliacs by Southern blotting. Thus far, either the CpG--,TpG mutation (Antonarakis et al., 1985; Gitschier et al., 1985; Youssoufian et al., 1986 Youssoufian et al., , 1987b Higuchi et al., 1987; Matthews et aL, 1987) or CpG--+ CpA mutation (Gitschier et al., 1986; Bernaldi et aL, 1987) has been observed in exons 18, 23, 24, and 26 of factor VIII gene. CpG --, TpG change caused a nonsense mutation from CGA (Arg) to TGA (stop codon), and the CpG -, CpA change caused a missense mutation from CGA (Arg) to CAA (Gin). Our case had a CpG--+ TpG mutation in exon 23. This mutation is the same as that reported by Matthews et al. (1987) . In Southern blot analysis, the abnormality of TaqI RFLP in exon 23 was also found in the mother of the patient. Carrier detection or prenatal diagnosis in this family can be performed by this analysis.
Anti-factor VIII antibodies (inhibitor) have been reported among patients caused by nonsense mutation in exon 18 (Higuchi et al., 1987; Matthews et al., 1987) , 23 (Matthews et al., 1987) , 24 (Gitschier et al., 1985; Higuchi et al., 1987) and 26 (Higuchi et al., 1987) but not by nonsense mutation in exon 22 (Youssoufian et al., 1986; Higuchi et al., 1987) . It has been also reported that missense mutations in exons 24 (Bernardi et al., 1987) and 26 (Gitschier et al., 1986) can cause a formation of anti-factor VIII antibodies (Table 1) . It is not easy to explain the relationship between molecular defects and inhibitor development. Several cases with various kinds of gene defects including nonsense, missense and deletion mutations of factor VIII gene were also found to have inhibitor (Antonarakis et al., 1985; Gitschier et al., 1985; Din et al., 1986; Camerino et al., 1986; Higuchi et al., 1987; Mikami et al., 1988) . To clarify the relationship, further studies of the defective factor VIII genes and their products should be performed. Vol. 33, No. 4, 1988 
